| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 5 | -878K | 100% | $0.63 | -$550K |
| Net | -5 | -878K | -100% | -$550K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Paula Ragan | President and CEO, Director | $392K | -$228K | -36.7% | Nov 15, 2024 |
| Mary DiBiase | Chief Operating Officer | $256K | -$57.4K | -18.3% | Oct 4, 2024 |
| Arthur Taveras | Chief Scientific Officer | $218K | -$56.7K | -20.6% | Oct 4, 2024 |
| Murray Stewart | Director | $169K | Jun 10, 2024 | ||
| Derek Meisner | Chief Legal Officer | $131K | Aug 17, 2022 | ||
| Keith Woods | Director | $119K | Jun 10, 2024 | ||
| Michael S. Wyzga | Director | $107K | Jun 10, 2024 | ||
| Diego Cadavid | Chief Medical Officer | $93.7K | Mar 1, 2022 | ||
| Francoise de Craecker | Director | $85.2K | Jun 10, 2024 | ||
| Gary Bridger | Director | $85.2K | Jun 10, 2024 | ||
| William Aliski | Director | $85.2K | Jun 10, 2024 | ||
| D. W. J. Mcgirr | Director | $85.2K | Jun 10, 2024 | ||
| Alison Frances Lawton | Director | $85.2K | Jun 10, 2024 | ||
| Mark Baldry | Chief Commercial Officer | $28.4K | -$6.51K | -18.7% | Oct 4, 2024 |
| Adam S. Mostafa | Chief Financial Officer | $0 | -$201K | -100% | Oct 4, 2024 |
| Rene Russo | Director | Jun 2, 2021 | |||
| Christophe Arbet-Engels | Chief Medical Officer | Feb 13, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|